(PSD) November 2016 PBAC Meeting - (Word 99KB)
(PSD) November 2016 PBAC Meeting - (Word 70KB)
(PSD) March 2016 PBAC Meeting
(PSD) March 2016 PBAC Meeting
(PSD) July 2015 PBAC Meeting
(PSA)-Based Population Screening for Prostate Cancer
(PSA) Test - Cancer Care Ontario
(proPSA) in Metastatic Prostate Cancer
(PRA) Skin Cancer - Beaumont Health System
(PPTX 6.45Mb)
(pembrolizumab) Receives Conditional Approval in Canada for the
(PDF, Unknown) - European Medical Journal
(pdf file, 949 kB) - AGO
(pdf file, 558 kB) - AGO
(PBS). Error bars represent SD. n=4
(PAWS1/FAM83G) is a substrate for type I BMP receptors and
(PARP) Inhibitors in Combination Therapy with Camptothecins or
(other than CRC) in IBD
(OG) Surgery
(NSABP) and Genomic Health, Inc. Announce Positive Results from
